argenx SE | ARGX - Current Liabilities

Stock Price
613.80
Daily Change
-2.20 -0.36%
Monthly
-12.04%
Yearly
11.40%
Q1 Forecast
598.33

argenx SE reported $1.04B in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
AstraZeneca USD 30.62B 3.44B Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
UCB EUR 3.53B 731M Dec/2024